Acute Asthma Exacerbation Management
Immediate Recognition and Assessment
Begin treatment immediately while assessing severity—do not delay bronchodilators or corticosteroids to "complete the assessment first." 1
Recognize severe exacerbation features: 2, 1
- Inability to complete sentences in one breath
- Respiratory rate >25 breaths/min
- Heart rate >110 beats/min
- Peak expiratory flow (PEF) <50% of predicted or personal best
Identify life-threatening features requiring immediate ICU consideration: 2, 1
- PEF <33% of predicted
- Silent chest, cyanosis, or feeble respiratory effort
- Altered mental status, confusion, or exhaustion
- Bradycardia or hypotension (ominous signs of impending arrest)
- Normal or elevated PaCO₂ (≥42 mmHg) in a breathless patient (indicates respiratory failure)
First-Line Immediate Treatment (Start ALL Simultaneously)
High-Dose Inhaled Beta-Agonist
Administer salbutamol 5 mg or terbutaline 10 mg via oxygen-driven nebulizer OR 4-8 puffs via metered-dose inhaler (MDI) with spacer every 20 minutes for 3 doses. 2, 1, 3 Both delivery methods are equally effective when properly administered. 1
Systemic Corticosteroids (Critical—Never Delay)
Give prednisolone 30-60 mg orally OR IV hydrocortisone 200 mg immediately—do not wait to "see if bronchodilators work first." 2, 1 Oral administration is as effective as IV and less invasive. 1 Clinical benefits require 6-12 hours minimum, making early administration essential. 4
Oxygen Therapy
Administer high-flow oxygen via face mask to maintain SaO₂ >90% (>95% in pregnant patients or those with heart disease). 1
Additional Treatment for Severe/Life-Threatening Features
If life-threatening features are present at initial assessment: 2, 1
Add ipratropium bromide 0.5 mg to nebulized beta-agonist every 20 minutes for 3 doses, then as needed—this combination reduces hospitalizations, particularly in severe airflow obstruction. 2, 1
Consider IV magnesium sulfate 2 g over 20 minutes for patients with severe refractory asthma or PEF <40% after initial treatment—this significantly increases lung function and decreases hospitalization necessity. 1
Give IV aminophylline 250 mg over 20 minutes OR salbutamol/terbutaline 250 µg over 10 minutes (but never give bolus aminophylline to patients already taking oral theophyllines). 2
Reassessment Protocol (15-30 Minutes After Initial Treatment)
Measure PEF and assess clinical response: 1
Good response (PEF ≥70% predicted):
- Continue oxygen, oral corticosteroids
- Transition to albuterol every 4-6 hours as needed
- Observe 30-60 minutes after last bronchodilator before discharge 1
Incomplete response (PEF 40-69% predicted):
- Continue intensive treatment every 20-60 minutes
- Admit to hospital ward 1
Poor response (PEF <40% predicted):
- Admit to hospital
- Consider ICU if life-threatening features present 1
Critical Pitfalls to Avoid
Never administer sedatives of any kind to patients with acute asthma—this is absolutely contraindicated. 2, 1
Do not underestimate severity—patients, families, and clinicians frequently fail to recognize dangerous exacerbations due to inadequate objective measurements. 2, 1 Always measure PEF or FEV₁.
Do not delay corticosteroids while "trying bronchodilators first"—they must be given immediately as benefits take 6-12 hours to manifest. 1, 4
Avoid methylxanthines (theophylline/aminophylline) in most cases due to erratic pharmacokinetics and significant side effects without superior efficacy. 1
Do not delay intubation once deemed necessary—it should be performed semi-electively before respiratory arrest occurs. 1
Hospital Admission Criteria
Immediate hospital referral required for: 2, 1
- Any life-threatening features
- Features of severe attack persisting after initial treatment
- PEF <33% of predicted after treatment
- Patients seen in afternoon/evening (lower threshold)
- Previous severe attacks, especially with rapid onset
- Concern over patient's ability to assess severity or poor social circumstances
Discharge Planning (After Stabilization)
Discharge criteria: 1
- PEF ≥70% of predicted or personal best
- Minimal or absent symptoms
- Oxygen saturation stable on room air
- Patient stable 30-60 minutes after last bronchodilator
Discharge medications: 1
- Continue oral corticosteroids for 5-10 days (no taper needed for courses <10 days)
- Initiate or continue inhaled corticosteroids
- Provide written asthma action plan
- Verify inhaler technique before discharge 1
Arrange follow-up within 1 week with primary care and within 4 weeks with specialist. 1